Biologics

SANUWAVE Appoints Alat Medika Indonesia as Distributor for dermaPACE and Liaison to Clinical Trials Participation for Company’s Wound Care Product(s) in Indonesia
Biologics Top Stories

SANUWAVE Appoints Alat Medika Indonesia as Distributor for dermaPACE and Liaison to Clinical Trials Participation for Company’s Wound Care Product(s) in Indonesia

SUWANEE, GA–(Marketwired – Jul 20, 2017) – SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the Company has appointed Alat Medika Indonesia as distributor for dermaPACE® and liaison for clinical trials participation for Company’s wound care product in Indonesia. The expected revenue from this agreement will be north of $1 million over the […]

Bioventus Expands EXOGEN® Performance Program in Canada to Include All Fracture Types
Biologics

Bioventus Expands EXOGEN® Performance Program in Canada to Include All Fracture Types

July 17, 2017 MISSISSAUGA, Ontario–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologics, today announced it has expanded the Performance Program* for its EXOGEN Ultrasound Bone Healing System to include delayed union and acute fractures. FDA PMA approved in 1994, EXOGEN has provided treatment to more than 1 million patients worldwide for more than 20 years and […]

PuraPly™ Antimicrobial Named One of Top 10 Innovations in Podiatry
Biologics Extremities

PuraPly™ Antimicrobial Named One of Top 10 Innovations in Podiatry

CANTON, Mass., July 13, 2017 /PRNewswire/ — PuraPlyTM Antimicrobial (PuraPlyTM AM), an FDA 510(k)-cleared wound management product from Organogenesis Inc., has been named one of the “Top 10 Innovations in Podiatry” by Podiatry Today, an award-winning publication that covers the latest developments in podiatric medicine. PuraPly AM was selected as a top innovation for 2017 for […]

FIDIA PHARMA USA Inc. Continues to Expand U.S. Presence as Fidia Farmaceutici S.p.A. Leads European Orthopedic Biomaterials Market
Biologics Top Stories

FIDIA PHARMA USA Inc. Continues to Expand U.S. Presence as Fidia Farmaceutici S.p.A. Leads European Orthopedic Biomaterials Market

July 11, 2017 PARSIPPANY, N.J.–(BUSINESS WIRE)–Fidia Farmaceutici S.p.A., a world leader in the research, development and manufacturing of hyaluronan (HA)-based products, and its wholly owned subsidiary, FIDIA PHARMA USA Inc., are projecting continued growth in 2017. The global viscosupplementation market is anticipated to increase to over $2.64 billion by 2021, […]

Regenexx Announces Successful Merger with Harbor View Medical
Biologics Top Stories

Regenexx Announces Successful Merger with Harbor View Medical

July 11, 2017 BROOMFIELD, Colo.–(BUSINESS WIRE)–Regenexx, a Colorado-based stem-cell-treatment network and pioneer in the invention of interventional orthopedics, today announced that it successfully merged with Harbor View Medical, a leader in orthopedic stem cell therapy and part of the Regenexx network, which became effective in May 2017. As part of the […]

InVivo Therapeutics Appoints Richard Toselli, M.D. as Chief Medical Officer
Biologics Neuro Top Stories

InVivo Therapeutics Appoints Richard Toselli, M.D. as Chief Medical Officer

July 10, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Richard Toselli, M.D., as Chief Medical Officer, effective July 5, 2017. Dr. Toselli, a fellowship-trained spinal neurosurgeon, will assume all responsibilities related to the company’s clinical and regulatory strategy. Prior to joining InVivo, Dr. Toselli served […]

Biologics

Smith & Nephew and University of Hull collaborate to drive research into pioneering approaches to advanced wound care

Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, and the University of Hull today announce a long-term collaboration driving research into pioneering approaches to advanced wound care. The partnership will create one of the world’s largest Wound Care Research Clusters, combining world-leading academia and industry with the aim of developing […]

Bone Therapeutics receives Intent to Grant Notice from European Patent Office for allogeneic bone cell therapy platform
Biologics Regulatory Top Stories

Bone Therapeutics receives Intent to Grant Notice from European Patent Office for allogeneic bone cell therapy platform

Gosselies, Belgium, 26 June 2017; 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today announces that the European Patent Office (EPO) has notified the Company of its intention to grant a key patent covering its […]

Kuros receives CE certification for Neuroseal®, a novel dural sealant
Biologics Regulatory Top Stories

Kuros receives CE certification for Neuroseal®, a novel dural sealant

Schlieren (Zurich), Switzerland, June 21, 2017 – Kuros Biosciences (SIX:KURN) announced today that it has received CE certification for its novel dural sealant, Neuroseal® . The CE certification allows for the commercialization of the product anywhere in the European Economic Area. As part of the supporting evidence, Neuroseal® has been […]